At the beginning of 2026, Aimeike announced that its exclusively imported botulinum toxin type A for injection, manufactured by Huons BioPharma of South Korea, had officially received approval from the National Medical Products Administration (NMPA) of China.This announcement marks the completion of
Jinan Fenghuang International Trade Co., Ltd. is a Sino-foreign joint venture high-tech enterprise focusing on the scientific and technological innovation and industrialization of biomedical new materials and medical device products with biomedical new materials as its core. Through the systematic c
Jinan Fenghuang International Trade Co., Ltd. is a Sino-foreign joint venture high-tech enterprise focusing on the scientific and technological innovation and industrialization of biomedical new materials and medical device products with biomedical new materials as its core. Through the systematic c